Business Context and Reporting Period
Company: DaVita HealthCare Partners Inc. (formerly DaVita Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2012
Event: The Company announced the consummation of the merger with HealthCare Partners Holdings, LLC ("HCP") on November 1, 2012. This filing updates the risk factors previously disclosed in the Company's Form 10-Q for the quarter ended September 30, 2012, to reflect the risks and uncertainties associated with HCP.
Financial Metrics
This Form 8-K is a disclosure of a material event (merger consummation) and an update to risk factors. It does not contain specific financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics for the reporting period. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
Merger Consummation: The primary material change is the completion of the merger between HCP and Seismic Acquisition LLC (a wholly-owned subsidiary of DaVita).
Risk Profile Update: The Company's risk factors have been expanded to include risks specific to HCP's operations, which differ from DaVita's traditional dialysis business. HCP operates as a managed care organization with significant exposure to capitation risks, regulatory changes in Medicare Advantage, and state-specific corporate practice of medicine laws.
Guidance, Outlook, and Risk Factors
The filing contains extensive forward-looking statements and a detailed list of risks related to HCP's business model. Key areas of concern include:
- Capitation and Risk-Sharing: Substantially all of HCP's revenue is derived from per-member per-month (PMPM) fees under capitation agreements. HCP assumes financial responsibility for medical costs; if expenses exceed estimates, profitability is directly impacted. Risk-sharing arrangements may require HCP to absorb deficits.
- Regulatory and Legislative Risks:
- Medicare Advantage: Reimbursement rates are subject to reductions under the Health Reform Acts and the Budget Control Act of 2011. Quality ratings of health plans directly affect reimbursement levels.
- Corporate Practice of Medicine: In California and Nevada, laws prohibit business entities from practicing medicine. HCP operates via management services agreements with physician groups. A regulatory determination that these arrangements violate state law could force a restructuring, invalidate contracts, or result in penalties.
- Financial Solvency: California regulations require affiliated physician groups to maintain a minimum "cash-to-claims ratio" of 0.75. Failure to comply could limit or terminate HCP's ability to do business in California.
- Concentration Risk: For the year ended December 31, 2011, 70% of HCP's consolidated medical revenues came from contracts with just three health plans. Termination or renegotiation of these contracts could materially affect results.
- Geographic Concentration: HCP operates exclusively in Florida, California, New Mexico, and Nevada, exposing it to regional economic conditions and natural disasters.
- Accounting and Estimation Risks: HCP relies on estimates for incurred but not reported (IBNR) claims. Inaccurate estimates or CMS audits regarding risk adjustment scores (RAF) could lead to revenue adjustments or refunds.
- Accountable Care Organizations (ACOs): HCP is participating in the "Pioneer ACO" program, which involves downside financial risk if cost savings targets are not met.
Key Facts for Investor Verification
- Verify the specific terms of the capitation agreements with the three health plans that generated 70% of HCP's 2011 revenue.
- Confirm HCP's current compliance status with California's "cash-to-claims ratio" solvency requirements.
- Assess the potential financial impact of the "Sustainable Growth Rate" (SGR) formula on Medicare fee-for-service reimbursements, noting the uncertainty of future Congressional intervention.
- Review the status of HCP's "Pioneer ACO" contracts and the potential for downside liability.
- Monitor any regulatory actions or litigation regarding the "corporate practice of medicine" in California and Nevada that could invalidate HCP's management service agreements.